as 04-01-2025 3:38pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Lexaria Bioscience Corp. LEXX prepares to release earnings report on 08 Apr 2025.
Founded: | 2004 | Country: | Canada |
Employees: | N/A | City: | KELOWNA |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $7.00 | AVG Volume (30 days): | 112.9K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.51 | EPS Growth: | N/A |
52 Week Low/High: | $1.15 - $4.44 | Next Earning Date: | 04-08-2025 |
Revenue: | $496,923 | Revenue Growth: | 77.63% |
Revenue Growth (this year): | 30.72% | Revenue Growth (next year): | 31.85% |
LEXX Breaking Stock News: Dive into LEXX Ticker-Specific Updates for Smart Investing
ACCESS Newswire
15 days ago
ACCESS Newswire
a month ago
ACCESS Newswire
a month ago
ACCESS Newswire
a month ago
ACCESS Newswire
2 months ago
ACCESS Newswire
2 months ago
ACCESS Newswire
2 months ago
ACCESS Newswire
2 months ago
The information presented on this page, "LEXX Lexaria Bioscience Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.